- Home
- WETH vs PULM Comparison
WETH vs PULM Comparison
Compare WETH & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WETH | PULM |
|---|---|---|
| Founded | 1992 | 2003 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6M | 13.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WETH | PULM |
|---|---|---|
| Price | $1.53 | $2.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 78.1K | 35.5K |
| Earning Date | 11-12-2025 | 10-16-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.55 | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | ★ $43,519,385.00 | $3,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $134.88 |
| P/E Ratio | $2.45 | ★ N/A |
| Revenue Growth | ★ 6.08 | N/A |
| 52 Week Low | $0.76 | $2.15 |
| 52 Week High | $3.68 | $10.40 |
Technical Indicators
Market Signals| Indicator | WETH | PULM |
|---|---|---|
| Relative Strength Index (RSI) | 44.23 | 27.33 |
| Support Level | $1.32 | $2.15 |
| Resistance Level | $1.57 | $2.36 |
| Average True Range (ATR) | 0.15 | 0.28 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 75.54 | 5.65 |
Price Performance
Historical ComparisonAbout WETH Wetouch Technology Inc.
Wetouch Technology Inc is a touch panel supplier focused on R&D, production, and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for the automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots, and charging stations. The company sells touchscreen products both domestically in China and internationally. The company generates the majority of its revenue from the PRC, followed by the Republic of China and Korea.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).